Lydia is a lecturer in the Microbiology and Infectious Disease Group at Swansea University Medical School. Lydia’s research, bridging engineering and biomedical sciences, uses atomic force microscopy to advance the biophysical understanding of complex 3D multicellular aggregates, such as bacterial biofilm structures and ovarian cancer spheroids. Lydia has translated this understanding into the design and delivery of new therapies for cystic fibrosis and chronic wound biofilm-related infections, where this research has informed the patenting and progression of novel anti-biofilm therapeutics into clinical trials (AlgiPharma AS and Qbiotics). Furthermore, Lydia investigates the impact of antimicrobial resistance (AMR) on biofilm dynamics, aiming to identify new therapeutic targets and pathways essential for developing effective treatments to combat AMR-related biofilm infections.
Lydia Powell
Recent AFM-related papers:
Biography: Lydia achieved a MEng in Chemical and Biochemical Engineering (1st class; 2005) and a MRes in Nanotechnology (2006), before completing a PhD in Biochemical Engineering (2011) at Swansea University.
In 2011, Lydia began her postdoctoral research career at Cardiff University, based at the University Hospital of Wales, investigating the use of novel antimicrobial agents to treat bacterial biofilm-related infections. In 2018, Lydia returned to Swansea University to characterise the effect of novel epigenetic and antibody-drug conjugate therapeutics on ovarian cancer 3D cell models. In 2022, Lydia became a Lecturer in Microbiology and Infectious disease within Swansea University and also holds an Honorary Lectureship position in Cardiff University.
ResearchGate: https://www.researchgate.net/profile/Lydia-Powell-2
LinkedIn: https://www.linkedin.com/in/lydia-powell-15732986/
Are you a woman conducting AFM research or know of someone you would like to nominate to be featured in our next #WomenInAFM campaign? Contact us at community@nunano.com!